Urothelial cancer organoids show promise as a tool for bladder cancer research
Researchers from the University Medical Center Utrecht (Netherlands) have provided proof of concept of tissue-based bladder tumoroids mimicking parental tumors.
Stem cell therapy for corneal damage demonstrates success in clinical trials
Harvard Medical School (HMS; MA, USA) surgeons have seen success in Phase I clinical trials of their recently developed stem cell therapy for the repair of damage to the cornea.
Engineered antibodies could have a role in regenerative medicine
Engineered antibodies have been shown to potently and specifically activate regenerative pathways in cells. It is possible that these engineered antibodies may form the basis of a new class of therapeutics in the regenerative medicine field.
stem cell-derived organoids produce tears in a dish
Researchers from the Hubrecht Institute (Utrecht, The Netherlands) have developed stem-cell-derived organoids that can produce moisture. This regenerative method may shed light – and tears – on novel treatments for dry-eye disease.
